De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Bliss GVS Pharma Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Gagan Sharma
Algemeen directeur
₹21.6m
Totale compensatie
| Percentage CEO-salaris | 100.0% |
| Dienstverband CEO | 3.4yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 3.4yrs |
| Gemiddelde ambtstermijn bestuur | 6.5yrs |
Recente managementupdates
Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19
Recent updates
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹815m |
| Mar 31 2024 | ₹22m | ₹22m | ₹755m |
| Dec 31 2023 | n/a | n/a | ₹879m |
| Sep 30 2023 | n/a | n/a | ₹883m |
| Jun 30 2023 | n/a | n/a | ₹598m |
| Mar 31 2023 | ₹18m | ₹18m | ₹709m |
| Dec 31 2022 | n/a | n/a | ₹871m |
| Sep 30 2022 | n/a | n/a | ₹91m |
| Jun 30 2022 | n/a | n/a | ₹165m |
| Mar 31 2022 | ₹15m | ₹15m | ₹150m |
| Dec 31 2021 | n/a | n/a | ₹17m |
| Sep 30 2021 | n/a | n/a | ₹773m |
| Jun 30 2021 | n/a | n/a | ₹766m |
| Mar 31 2021 | ₹1m | ₹1m | ₹685m |
Compensatie versus markt: De totale vergoeding ($USD 258.16K ) Gagan } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 184.73K ).
Compensatie versus inkomsten: De vergoeding van Gagan is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Gagan Sharma (41 yo)
3.4yrs
Tenure
₹21,639,379
Compensatie
Mr. Gagan Harsh Sharma serves as Managing Director at Bliss GVS Pharma Limited since May 11, 2021 and its Director since January 21, 2021. He served as Vice President of Strategy and Business Development a...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 3.4yrs | ₹21.64m | geen gegevens | |
| Chief Financial Officer | 1.8yrs | ₹6.48m | geen gegevens | |
| Compliance Officer | 6.2yrs | ₹1.84m | geen gegevens | |
| Executive & Whole Time Director | no data | ₹7.41m | 2.01% ₹ 292.9m | |
| Vice President of Technical Operations | no data | geen gegevens | geen gegevens | |
| Executive & Whole Time Director | no data | ₹7.05m | 2.35% ₹ 343.5m | |
| Associate Vice President | no data | geen gegevens | geen gegevens |
3.4yrs
Gemiddelde duur
41yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van BLISSGVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 3.8yrs | ₹21.64m | geen gegevens | |
| Executive & Whole Time Director | 18.3yrs | ₹7.41m | 2.01% ₹ 292.9m | |
| Executive & Whole Time Director | 16.3yrs | ₹7.05m | 2.35% ₹ 343.5m | |
| Independent Women Director | 4.7yrs | ₹375.00k | geen gegevens | |
| Independent Non-Executive Director | 8.4yrs | ₹375.00k | geen gegevens | |
| Additional Independent Director | less than a year | geen gegevens | geen gegevens |
6.5yrs
Gemiddelde duur
45.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van BLISSGVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).